Evidence map›Paper›PMID 32266150›Full record

ArticleFrontiers in oncology2020

BCL11A Promotes the Progression of Laryngeal Squamous Cell Carcinoma.

Jian Zhou, Liang Zhou, Duo Zhang, Wei-Jing Tang, Di Tang, Xiao-Ling Shi, Yue Yang, Lin Zhou, Fei Liu, Yong Yu and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Current cancer drug targets · 2022
    Article
  12. Article
  13. High Expression ofFrontiers in oncology · 2021
    Article
  14. Laryngeal Squamous Cell Carcinoma: Potential Molecular Mechanism and Prognostic Signature Based on Immune-Related Genes.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Jian ZhouShanghai Institute of Immunology, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Liang ZhouDepartment of Otolaryngology, Eye, Ear, Nose and Throat Hospital, Fudan University, Shanghai, China.
Duo ZhangDepartment of Otolaryngology, Eye, Ear, Nose and Throat Hospital, Fudan University, Shanghai, China.
Wei-Jing TangDepartment of Otolaryngology, Eye, Ear, Nose and Throat Hospital, Fudan University, Shanghai, China.
Di TangDepartment of Otolaryngology, Eye, Ear, Nose and Throat Hospital, Fudan University, Shanghai, China.
Xiao-Ling ShiDepartment of Otolaryngology, Eye, Ear, Nose and Throat Hospital, Fudan University, Shanghai, China.
Yue YangDepartment of Otolaryngology, Eye, Ear, Nose and Throat Hospital, Fudan University, Shanghai, China.
Lin ZhouShanghai Institute of Immunology, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Fei LiuShanghai Institute of Immunology, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Yong YuWellcome Trust Sanger Institute, Cambridge, United Kingdom.
Pentao LiuWellcome Trust Sanger Institute, Cambridge, United Kingdom.
Lei TaoDepartment of Otolaryngology, Eye, Ear, Nose and Throat Hospital, Fudan University, Shanghai, China.
Li-Ming LuShanghai Institute of Immunology, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Fudan University · CNShanghai Clinical Research Center · CNShanghai Jiao Tong University · CNWellcome Sanger Institute · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BCL11ALSCCMDM2prognosisproto-oncogene

Identifiers

PMID32266150
PMCPMC7098986
OpenAlexW3023963685

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.